• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Invacare’s Q4, 2009 profits rise

Invacare’s Q4, 2009 profits rise

February 4, 2010 By MedCity News

By Mary Vanac

MedCity News logo

ELYRIA, Ohio — Home healthcare products maker Invacare Corp. (NYSE:IVC) is closing the books on a strong financial performance in 2009 “despite a challenging reimbursement and economic environment,” chairman and CEO A. Malachi Mixon III said.

In the fourth quarter, net earnings rose 6 percent to $17.6 million, or 55 cents per diluted share, from $16.6 million, or 52 cents per diluted share, in the year-ago quarter. For the year, net earnings were up 18 percent to $41.2 million, or $1.29 per diluted share, from $34.9 million, or $1.09 per diluted share, mostly because of a more favorable tax rate.

Adjusted earnings per share, which exclude one-time items like restructuring costs, rose 5 percent in the fourth quarter to 63 cents, and 17 percent for the year, to $1.58, from the year-ago periods.

Free cash flow, which is a measure of net cash Invacare generated after paying bills and making investments, was $61.8 million in the quarter, up from $56.5 million a year ago. For the year, free cash flow was $141.6 million, up more than two times from $59.9 million 2008.

Net sales rose 4 percent to $448.6 million in the quarter and fell 4 percent to $1.7 billion in the year from the year-ago periods. “Organic sales” — those that come from operations not from acquisitions or foreign currency adjustments — increased 0.3 percent in the quarter and decreased 0.2 percent for the year.

Invacare expects organic sales to increase between 1 percent and 3 percent in 2010. It also expects adjusted earnings per share of between $1.70 and $1.80, and free cash flow of between $65 million and $75 million.

“This improvement will be built upon 2009’s successful cost reductions, as well as a return to organic sales growth, both driven by globalization and exciting new product introductions,” Mixon said in his company’s earnings release. “The company plans to use its projected strong free cash flow … to continue to retire debt or pursue accretive acquisitions, as available.”

And one Invacare specter appears to have been vanquished — a tax on medical device sales proposed under health care reform that would have cost Invacare between $12 million and $14 million a year.

“The primary reimbursement risk for Invacare in 2010 … is related to health care reform in the United States,” Mixon said. “However, the likelihood of a massive health care reform bill has been diminished by the outcome of the Senate election in Massachusetts. The Obama Administration’s number one priority seems to have moved from health care to jobs and the economy. As a result, the Company is optimistic that the medical device excise tax will not materialize, although there is still discussion in Congress on how to achieve health care reform in the future.”

To start saving money this year to pay the expected medical device tax next year, last month Invacare suspended some benefits for employees, including matching contributions to its 401(k) retirement plan and merit pay increases for managers, as well as frozen new hiring.

Invacare shares were up more than 6 percent to $26.23 in late-morning trading on the New York Stock Exchange.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: Home Healthcare, Invacare

More recent news

  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy